Skip to main content

Table 3 Price in U.S. dollars of anti-malarial medicines and malaria rapid diagnostic tests by drug-outlet type in Siaya County, Kenya—2013

From: A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013

 

Overall median

Overall mean (range)

Registered pharmacy mean (range)

Informal shop mean (range)

General shop mean (range)

Homestead mean (range)

Other mean (range)

Price in U.S. dollars ($)a

Artemisinin-based combination therapy

 Artemether-lumefantrine

0.94

1.01

(0.35–4.71)

1.28

(0.35–4.71)

1.00

(0.35–2.94)

0.92

(0.35–1.76)

1.09

(0.71–1.76)

1.06

(0.94–1.41)

 Dihydroartemisinin-piperaquine

4.14

4.39

(0.71–7.06)

4.38

(0.71–7.06)

4.45

(3.53–5.29)

4.12

(3.53–4.71)

 Artesunate-amodiaquine

0.71

0.71

(0.59–1.18)

0.63

(0.59–0.71)

0.73

(0.59–1.18)

0.71

(NAb)

0.82

(NA)

 Artemisinin-piperaquine

5.47

5.53

(5.29–5.88)

5.61

(5.29–5.88)

5.29

(NA)

Quinine formulations

 Tablets

2.31

2.24

(0.12–4.71)

2.93

(1.09–4.71)

1.86

(0.12–3.53)

2.82

(NA)

1.62

(0.59–2.65)

2.35

(0.88–3.81)

 Parenteral (600 mg/2 ml vial)

0.35

0.48

(0.24–1.06)

0.50

(0.24–1.06)

0.51

(0.29–1.06)

0.41

(0.35–0.47)

0.41

(NA)

0.33

(0.29–0.35)

 Paediatric suspensionc (50 mg/5 ml)

0.82

0.94

(0.53–2.35)

0.75

(0.53–0.94)

1.00

(0.53–2.35)

0.82

(NA)

Sulfadoxine-pyrimethamine

0.47

0.62

(0.24–2.35)

0.76

(0.29–1.76)

0.68

(0.35–2.35)

0.39

(0.24–0.82)

0.50

(0.35–0.82)

0.91

(0.35–1.76)

Amodiaquine monotherapy

0.35

0.42

(0.24–1.06)

0.33

(0.29–0.35)

0.45

(0.24–1.06)

0.35

(NA)

Artemether, parenteral (80 mg/ml vial)

1.18

1.53

(0.47–4.12)

1.75

(0.94–4.12)

0.82

(0.47–1.18)

1.18

(NA)

Malaria rapid diagnostic tests

0.59

0.92

(0.24–2.35)

1.02

(0.35–2.35)

0.87

(0.24–2.35)

0.71

(0.35–1.18)

  1. Price per standard adult-equivalent treatment dose for all medicines except parenteral and paediatric suspension formulations
  2. aAll prices in U.S. dollars (USD) converted from Kenya Shillings (KES) based on exchange rate in October 2013 (1 USD = 85 KES)
  3. b NA not applicable. Only one price for the medicine formulation; no range reported
  4. cPrice analysis for most common formulation only, which represented 87.5 % (21/24) of total